Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Therapix Biosciences Ltd ADR
TRPXY
Healthcare
Biotechnology
Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid...
molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:TRPXY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
(0)
•••
easyas123
X
View Profile
View Bullboard History
Comment by
easyas123
on Dec 03, 2018 10:09am
RE:RE:RE:RE:RE:News Release
I think the rather quick response of getting the Q3 financials issued shows they are doing what they need to do to satisfy the requirements of getting the deal done. I would expect we hear something
...more
(16)
•••
edmed
X
View Profile
View Bullboard History
Comment by
edmed
on Dec 03, 2018 9:56am
RE:RE:RE:RE:News Release
Now that the third quarter financials are out is the ball now in FSD pharma's court with respect to closing the deal??? If so when do you think we find out which way they are leaning? Stock
...more
(0)
•••
easyas123
X
View Profile
View Bullboard History
Comment by
easyas123
on Nov 30, 2018 10:24pm
RE:RE:RE:News Release
I would think they would no how important it is to get them completed if in fact the $48 million offer is a good deal. They better be doing absolutely everything they need to be doing to get this done
...more
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Comment by
Fundy13
on Nov 30, 2018 4:47pm
RE:RE:News Release
TRPX has never responded to my emails. I have trie dto call twice, but I think the time difference makes it difficult to get them during business hours. Maybe TRPX is using some of the cash it
...more
(0)
•••
easyas123
X
View Profile
View Bullboard History
Comment by
easyas123
on Nov 30, 2018 2:11pm
RE:News Release
Just got this response from FSD IR. Have you had any luck getting anything back from TRPX IR? Hello, Unfortunately FSD Pharma cant proceed further with the transaction if Therapixs Q3 financials arent
...more
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Post by
Fundy13
on Nov 26, 2018 1:41pm
News Release
This is the news release put on on teh TRPX deal in Isreal. Tranlate to english and give it a read. It has more details the the Canadiand and US release. Main one being it
...more
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Comment by
Fundy13
on Nov 26, 2018 11:29am
RE:RE:RE:RE:From Analyst
Always better to under promise and over delivery. If you are not confident in teh 30 day timeline then best to say 45 or 60 days. Nobody will complian if you say 60 days and it closes in
...more
(0)
•••
easyas123
X
View Profile
View Bullboard History
Comment by
easyas123
on Nov 26, 2018 11:16am
RE:RE:RE:From Analyst
Hopefully it is just nervous people who are already in the money locking in profits. Doesn't help whenever deadlines are not met.
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Comment by
Fundy13
on Nov 26, 2018 10:17am
RE:RE:From Analyst
I understand there are always risks before the difinitive agreement is signed and we are after the 30 days that was indicated in the press release so I could see some people getting nervous. But
...more
(16)
•••
edmed
X
View Profile
View Bullboard History
Comment by
edmed
on Nov 26, 2018 9:59am
RE:From Analyst
I can't believe this is still trading so low market really does not expect this deal to go through????? edmed
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Post by
Fundy13
on Nov 26, 2018 8:48am
HUGE Aquisition
I never like when things are delayed beyond the timeline laid out in the original news release. However since the announcement of the binding LOI everytime anything from HUGE somes out they make
...more
(2)
•••
StuinSea
X
View Profile
View Bullboard History
Post by
StuinSea
on Nov 23, 2018 7:46pm
Q & A with the company - Must Read
questionaire response.pdf
(0)
•••
easyas123
X
View Profile
View Bullboard History
Comment by
easyas123
on Nov 23, 2018 1:34pm
RE:RE:From Analyst
Interesting that someone did not want to let it close above $7.60. Makes me a bit nervous.
(2)
•••
Mining_Engineer_UBC
X
View Profile
View Bullboard History
Comment by
Mining_Engineer_UBC
on Nov 21, 2018 1:09pm
RE:From Analyst
Great info! Thanks for sharing.
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Post by
Fundy13
on Nov 21, 2018 12:30pm
From Analyst
I emailed the two analyists who coverTRPX and one just got back to me. Confimred the info I found that the final number will be $12US per share for TRPX holders. Also wanted to mention that this
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >